Virchow Medical completed a $4 million seed financing led by Cerberus Ventures to expand development of its liquid specimen biorepository, the Virchow Vault. The company plans to deploy “biopsy catchment” pilot programs using its Crow’s Nest system to capture residual tumor cells from discarded biopsy needles and run concordance studies against standard formalin-fixed tissue sampling.